• South Africa’s intellectual property developments – heading in the wrong direction?

    Pugatch Consilium’s Prof. Meir Pugatch and Consultant Jacques Stemmet publish an article in the Financial Times’ fDi Magazine, discussing the future of South Africa’s intellectual property environment and its impact on access to medicines and pharmaceutical FDI.

    South Africa’s intellectual property developments – heading in the wrong direction?
     
  • Professor Meir Pugatch Portuguese Interview: Brazil will have economic and social benefits to the development of biotechnology

    Expert at the University of Haifa (Israel) has presented on Tuesday (29/April/2014), a recent study on the biotechnology market in eight countries: Full article in Portuguese

    Professor Meir Pugatch Portuguese Interview: Brazil will have economic and social benefits to the development of biotechnology
     
  • New Report on the Value of Cross-Border Data

    Pugatch Consilium has launched a new report, At the Cutting Edge, on the benefits of cross-border data to consumers, companies and governments. The report considers the value and applications of cross-border data in different countries around the world today. It analyzes a wide range of personal, social and economic benefits using case studies and anecdotes as well as statistical analysis. The report also presents a set of enabling and deterrent factors of these flows. Download a copy from the Research & Analysis Reports page.

    New Report on the Value of Cross-Border Data
     
  • Intellectual Property: Bristol-Myers Squibb and the Medicines Patent Pool – An Unlikely Marriage?

    The Role of the Medicines Patent Pool in Stimulating the Development and Availability of Global Health Medicines. Full article at the Lexxion Website

    Intellectual Property: Bristol-Myers Squibb and the Medicines Patent Pool – An Unlikely Marriage?
     
  • On Intellectual Property, A New Strategy

    India could use IP rights to take its rightful place as a leader in global innovation. Read the full article written by Professor Meir Pugatch at The Indian Express

    On Intellectual Property, A New Strategy
     
  • When National Champions Fall

    The case of Teva requires us to revise our thinking about national champions and national interests;
    Prof. Meir Perez Pugatch addresses the current situation with Teva pharmaceuticals – the biggest generics company in the world – in Israel and how it has been impacted by the patent expiration of Copaxon. Full article at Pharmaphorum Media

    When National Champions Fall
     
  • Professor Meir Pugatch at the Montréal InVivo/LSO – Breakfast round-table IP protection – Ottawa

    Prof. Meir Pugatch presenting at the Montréal InVivo/LSO – Breakfast round-table IP protection in Ottawa

    Full video at: http://www.youtube.com/watch?v=IkmC5DQ5b88&feature=youtu.be

    Professor Meir Pugatch at the Montréal InVivo/LSO – Breakfast round-table IP protection – Ottawa
     
  • Innovative Drug Research & Development in Russia Conference

    Prof. Pugatch will be moderating the regulatory panel on: Government support, strategies and policies for promoting R&D, at the 4th Annual “Innovative Drug Research & Development in Russia” Conference, 19 November 2013

    Innovative Drug Research & Development in Russia Conference
     
  • Rule of Law

    Pugatch Consilium and the Coalition for the Rule of Law in Global Markets Introduce the Global Business Rule of Law Dashboard at the AACCLA’s 46th Annual Meeting -Forecast on Latin America and the Caribbean” Conference, 30 September 2013 View the Presentation

    Rule of Law
     
  • More Voices Enter Clinical Trials Data Sharing Debate in Europe

    Pugatch Consilium’s paper released last week, receives an overview by PhRMA!  Read more at: http://phrma.org/catalyst/more-voices-clinical-trials-data-sharing-debate-europe

    More Voices Enter Clinical Trials Data Sharing Debate in Europe
     

Pugatch Consilium provides evidence-based intelligence that helps clients in the fastest growing sectors optimise their performance Continue reading »